Dow Up 1.13% Nasdaq Up 1.41%

Alexza Pharmaceuticals Inc. (ALXA)

-NasdaqGM
2.26 Down 0.29(11.37%) Oct 31, 4:00PM EDT
Prev Close:2.55
Open:2.54
Bid:2.03 x 2000
Ask:2.40 x 1000
1y Target Est:9.50
Beta:1.99
Next Earnings Date: 5-Nov-14ALXA Earnings announcement
Day's Range:2.21 - 2.54
52wk Range:1.99 - 5.93
Volume:229,644
Avg Vol (3m):155,523
Market Cap:39.26M
P/E (ttm):N/A
EPS (ttm):-2.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXA

Comparison

Symbol% ChgMkt Cap
ALXADown 11.37%39.26M
ALKSDown 1.44%7.38B
ARDMUp 1.56%114.83M
LLYDown 0.70%71.26B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.42
Quarterly EPS Est (Sep-14) :-0.74
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexza Pharmaceuticals, Inc., a pharmaceutical company, focuses on the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback